| General Information of Drug Metabolite (DM) (ID: DM019978) |
| DM Name |
O-demethyl dexloxiglumide
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 2C9 (CYP2C9)
|
DME0019
|
| Unclear - Unclear |
CR-2017
|
[1] |
|
Cytochrome P450 3A4 (CYP3A4)
|
DME0001
|
| Unclear - Unclear |
CR-2017
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| CR-2017 |
DR0470
|
Phase 3 |
Irritable bowel syndrome |
|
|
| References |
| 1 |
Effect of azole antifungals ketoconazole and fluconazole on the pharmacokinetics of dexloxiglumide. Br J Clin Pharmacol. 2005 Nov;60(5):498-507.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
